Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China
- PMID: 19955093
- DOI: 10.1093/heapol/czp056
Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China
Abstract
Objective: To investigate the availability of essential medicines and their prices in Hubei province.
Methods: The survey assessed the prices and availability of essential medicines using the World Health Organization and Health Action International methodology. Data were collected from 18 public hospitals and 18 private pharmacies. At each facility the availability and prices of 39 innovator brand medicines and lowest-price generic equivalent medicines were collected. Medicine prices were compared with international reference prices to obtain a median price ratio (MPR). Daily incomes of low and average levels were used to assess the affordability of the medicines.
Findings: Median availability in the public and private sectors was low (38.9% and 44.4% for lowest-price generics, respectively). The median MPRs of procurement prices for innovator brands and lowest-price generics in the public sector were 9.78 and 0.74 times the international reference prices; and the median MPRs of retail prices to patients for lowest-price generics in the public sector (1.04) were higher than those in the private sector (0.68). For most of the population, the medicine prices are affordable, but for those of low income they are not.
Conclusions: The survey revealed low procurement prices but poor availability in the public sector. Various policy adjustments could increase the availability of essential medicines and reduce their prices for the low income population.
Similar articles
-
Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.Lancet Glob Health. 2013 Oct;1(4):e227-37. doi: 10.1016/S2214-109X(13)70072-X. Epub 2013 Sep 24. Lancet Glob Health. 2013. PMID: 25104348
-
High medicine prices and poor affordability.Curr Opin Psychiatry. 2011 Jul;24(4):341-5. doi: 10.1097/YCO.0b013e3283477b68. Curr Opin Psychiatry. 2011. PMID: 21532479 Review.
-
[Mechanism and implication of regulation of the pricing of essential medicines in the private pharmaceutical sector in Mali].Med Trop (Mars). 2010 Apr;70(2):184-8. Med Trop (Mars). 2010. PMID: 20486360 Review. French.
-
Prices & availability of common medicines at six sites in India using a standard methodology.Indian J Med Res. 2007 May;125(5):645-54. Indian J Med Res. 2007. PMID: 17642500
-
Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.PLoS Med. 2007 Mar 27;4(3):e82. doi: 10.1371/journal.pmed.0040082. PLoS Med. 2007. PMID: 17388660 Free PMC article.
Cited by
-
Long way to go: Progress of orphan drug accessibility in China from 2017 to 2022.Front Pharmacol. 2023 Mar 8;14:1138996. doi: 10.3389/fphar.2023.1138996. eCollection 2023. Front Pharmacol. 2023. PMID: 36969835 Free PMC article.
-
Price and affordability of key essential medicines for children in Sri Lanka, a lower-middle-income country: comparison of two national cross-sectional surveys done 8 years apart.BMJ Open. 2023 Feb 17;13(2):e069733. doi: 10.1136/bmjopen-2022-069733. BMJ Open. 2023. PMID: 36806061 Free PMC article.
-
Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan.Int J Public Health. 2022 Jul 6;67:1604375. doi: 10.3389/ijph.2022.1604375. eCollection 2022. Int J Public Health. 2022. PMID: 35872706 Free PMC article.
-
Evaluating the Price, Availability, and Affordability of Essential Medicines in Primary Healthcare Institutions: A Mixed Longitudinal and Cross-Sectional Study in Jiangsu, China.Front Public Health. 2022 Apr 12;10:860471. doi: 10.3389/fpubh.2022.860471. eCollection 2022. Front Public Health. 2022. PMID: 35493374 Free PMC article.
-
Impact of the National Health Insurance Coverage Policy on the Utilisation and Accessibility of Innovative Anti-cancer Medicines in China: An Interrupted Time-Series Study.Front Public Health. 2021 Aug 6;9:714127. doi: 10.3389/fpubh.2021.714127. eCollection 2021. Front Public Health. 2021. PMID: 34422752 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical